Curexo Inc. (060280.KQ)

KRW 8370.0

(-1.53%)

Total Liabilities Summary of Curexo Inc.

  • Curexo Inc.'s latest annual total liabilities in 2023 was 6.94 Billion KRW , down -58.48% from previous year.
  • Curexo Inc.'s latest quarterly total liabilities in 2024 Q1 was 6.96 Billion KRW , up 0.37% from previous quarter.
  • Curexo Inc. reported annual total liabilities of 16.71 Billion KRW in 2022, down -9.17% from previous year.
  • Curexo Inc. reported annual total liabilities of 18.4 Billion KRW in 2021, up 350.64% from previous year.
  • Curexo Inc. reported quarterly total liabilities of 10.47 Billion KRW for 2024 Q2, up 50.32% from previous quarter.
  • Curexo Inc. reported quarterly total liabilities of 6.94 Billion KRW for 2023 Q4, down -13.46% from previous quarter.

Annual Total Liabilities Chart of Curexo Inc. (2023 - 2016)

Historical Annual Total Liabilities of Curexo Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 6.94 Billion KRW -58.48%
2022 16.71 Billion KRW -9.17%
2021 18.4 Billion KRW 350.64%
2020 4.08 Billion KRW 29.84%
2019 3.14 Billion KRW -4.96%
2018 3.3 Billion KRW -31.91%
2017 4.86 Billion KRW -5.93%
2016 5.16 Billion KRW 0.0%

Peer Total Liabilities Comparison of Curexo Inc.

Name Total Liabilities Total Liabilities Difference
Osang Healthcare Co.,Ltd 27.25 Billion KRW 74.534%
InBody Co.,Ltd 24.62 Billion KRW 71.809%
Seegene, Inc. 221.05 Billion KRW 96.86%
i-SENS, Inc. 195.32 Billion KRW 96.446%
Ray Co., Ltd. 128.35 Billion KRW 94.592%
Gencurix Inc. 21.49 Billion KRW 67.714%
Sugentech Inc. 20.73 Billion KRW 66.52%
L&C Bio Co., Ltd 105.37 Billion KRW 93.413%